Transforming growth factor-β1 and soluble co-inhibitory immune checkpoints as putative drivers of immune suppression in patients with basal cell carcinoma

Transforming growth factor-β1 and soluble co-inhibitory immune checkpoints as putative drivers of immune suppression in patients with basal cell carcinoma

The current study compared the levels and possible associations between systemic soluble immune checkpoints (sICPs, n = 17) and a group of humoral modulators of immune suppressor cells (n = 7) in a cohort of patients with basal cell carcinoma (BCC, n = 40) and a group of healthy control subjects (n...

Full description

Bibliographic Details
Main Authors: Mahlatse C.M. Kgokolo, Nonkululeko Z. Malinga, Helen C. Steel, Pieter W.A. Meyer, Teresa Smit, Ronald Anderson, Bernardo L. Rapoport
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Translational Oncology
Subjects:
Arginase 1
Basal cell carcinoma
CTLA-4 antigen
PD-L1
Regulatory T-lymphocytes
Transforming growth factor-β1
Online Access:http://www.sciencedirect.com/science/article/pii/S193652332300253X

Internet

http://www.sciencedirect.com/science/article/pii/S193652332300253X

Similar Items